# Specification Quality Checklist: GECKO documentation header and enzyme-aware diagnostics

**Purpose**: Validate specification completeness and quality before proceeding to planning
**Created**: 2026-07-16
**Feature**: [spec.md](../spec.md)

## Content Quality

- [x] No implementation details (languages, frameworks, APIs)
- [x] Focused on user value and business needs
- [x] Written for non-technical stakeholders
- [x] All mandatory sections completed

## Requirement Completeness

- [x] No [NEEDS CLARIFICATION] markers remain
- [x] Requirements are testable and unambiguous
- [x] Success criteria are measurable
- [x] Success criteria are technology-agnostic (no implementation details)
- [x] All acceptance scenarios are defined
- [x] Edge cases are identified
- [x] Scope is clearly bounded
- [x] Dependencies and assumptions identified

## Feature Readiness

- [x] All functional requirements have clear acceptance criteria
- [x] User scenarios cover primary flows
- [x] Feature meets measurable outcomes defined in Success Criteria
- [x] No implementation details leak into specification

## Notes

- The three flagged decisions are now RESOLVED in Clarifications Session 2026-07-17 (all confirmed to
  the recommended defaults): enzyme-KKT derived analytically + verified vs both backends' duals; ALL
  affected printLevel>1 blocks in scope; residual-assertion + non-enzyme characterization test strategy.
  No unresolved [NEEDS CLARIFICATION] marker remains.
- Characterization mode (Principle III) applies to Part 2: the non-enzyme printed-diagnostic
  invariance (FR-004/SC-004) is the pinned existing contract.
